Jorden David Emerson
- SEC CIK
- 0001313516
In the past year, 1 open-market purchase filing worth $9.54K and 1 sale filing worth $300.0K.
Current role at each company
- AURX Nuo Therapeutics, Inc.CEO/CFOas of Aug 31, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $9.54K
- 1 filing
- Sold
- $300.0K
- 1 filing
- Net
- −$290.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Jorden David Emerson as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 (view filing)10:29 AM ET | Aug 27-28 | 4 days | Jorden David EmersonCEO/CFO | PPurchase | +8.77K | $1.09 | +$9.54K | +0.4%2.07M after | Amended2 lots |
| Dec 3, 2025 (view filing) | Nov 28 | 5 daysLate | Jorden David EmersonCEO/CFO | SSale | −200.0K | $1.50 | −$300.0K | −9.3%1.95M after | |
| Nov 14, 2022 (view filing) | Nov 9 | 5 days | Jorden David EmersonCEO/CFO | SSale | −162.5K | $1.50 | −$243.8K | −7.6%1.98M after | 9 lots |